Advertisement

Fluorescence Imaging of Breast Tumors and Gastrointestinal Cancer

Chapter
First Online:
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 216)

Abstract

Optical imaging offers a high potential for noninvasive detection and therapy of cancer in humans. Recent advances in instrumentation for diffuse optical imaging have led to new capabilities for the detection of cancer in highly scattering tissue such as the female breast. In particular, fluorescence imaging was made applicable as a sensitive technique to image molecular probes in vivo. We review recent developments in the detection of breast cancer and fluorescence-guided surgery of the breast by contrast agents available for application on humans. Detection of cancer has been investigated with the unspecific contrast agents “indocyanine green” and “omocianine” so far. Hereby, indocyanine green was found to offer high potential for the differentiation of malignant and benign lesions by exploiting vessel permeability for macromolecules as a cancer-specific feature. Tumor-specific molecular targeting and activatable probes have been investigated in clinical trials for fluorescence-guided tumor margin detection. In this application, high spatial resolution can be achieved, since tumor regions are visualized mainly at the tissue surface. As another example of superficial tumor tissue, imaging of lesions in the gastrointestinal tract is discussed. Promising results have been obtained on high-risk patients with Barrett´s esophagus and with ulcerative colitis by administering 5-aminolevulinic acid which induces accumulation of protoporphyrin IX serving as a tumor-specific fluorescent marker. Time-gated fluorescence imaging and spectroscopy are effective ways to suppress underlying background from tissue autofluorescence. Furthermore, recently developed tumor-specific molecular probes have been demonstrated to be superior to white-light endoscopy offering new ways for early detection of malignancies in the gastrointestinal tract.

Keywords

Optical molecular imaging Fluorescence imaging of cancer Fluorescence-guided surgery Fluorescence endoscopy Breast cancer Esophageal cancer Colon cancer Dysplasia 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Amini A, Masoumi Moghaddam S, Morris DL, Pourgholami MH (2012) The critical role of vascular endothelial growth factor in tumor angiogenesis. Curr Cancer Drug Targets 12:23–43. https://doi.org/10.2174/156800912798888956CrossRefPubMedGoogle Scholar
  2. 2.
    Baumgartner R, Krammer B, Pottier R, Stepp H (eds) (2007) Photodynamic therapy with ALA. Royal Society of Chemistry, CambridgeGoogle Scholar
  3. 3.
    Becker A, Hessenius C, Licha K et al (2001) Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 19:327–331.  https://doi.org/10.1038/86707CrossRefPubMedGoogle Scholar
  4. 4.
    Betz CS, Stepp H, Janda P et al (2002) A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer 97:245–252. https://doi.org/10.1002/ijc.1596CrossRefPubMedGoogle Scholar
  5. 5.
    Boerwinkel DF, Holz JA, Kara MA et al (2014) Effects of autofluorescence imaging on detection and treatment of early neoplasia in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol 12:774–781.  https://doi.org/10.1016/j.cgh.2013.10.013CrossRefPubMedGoogle Scholar
  6. 6.
    Brand S, Wang TD, Schomacker KT et al (2002) Detection of high-grade dysplasia in Barrett’s esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc 56:479–487.  https://doi.org/10.1067/mge.2002.128172CrossRefPubMedGoogle Scholar
  7. 7.
    Bremer C, Tung C-H, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7:743–748.  https://doi.org/10.1038/89126CrossRefPubMedGoogle Scholar
  8. 8.
    Bremer C, Tung C-H, Bogdanov A, Weissleder R (2002) Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology 222:814–818.  https://doi.org/10.1148/radiol.2223010812CrossRefPubMedGoogle Scholar
  9. 9.
    Bremer C, Ntziachristos V, Weitkamp B et al (2005) Optical imaging of spontaneous breast tumors using protease sensing “smart” optical probes. Invest Radiol 40:321–327. https://doi.org/10.1097/01.rli.0000163797.23172.90CrossRefPubMedGoogle Scholar
  10. 10.
    Burggraaf J, Kamerling IMC, Gordon PB et al (2015) Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met. Nat Med 21:955–961.  https://doi.org/10.1038/nm.3641CrossRefPubMedGoogle Scholar
  11. 11.
    Cauberg ECC, de Bruin DM, Faber DJ et al (2009) A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol 56:287–297.  https://doi.org/10.1016/j.eururo.2009.02.033CrossRefPubMedGoogle Scholar
  12. 12.
    Cerussi AE, Shah N, Hsiang D et al (2006) In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 11:044005.  https://doi.org/10.1117/1.2337546CrossRefPubMedGoogle Scholar
  13. 13.
    Chance B, Nioka S, Zhang J et al (2005) Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol 12:925–933.  https://doi.org/10.1016/j.acra.2005.04.016CrossRefPubMedGoogle Scholar
  14. 14.
    Corlu A, Choe R, Durduran T et al (2007) Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Express 15:6696–6716. https://doi.org/10.1364/oe.15.006696CrossRefPubMedGoogle Scholar
  15. 15.
    Cubeddu R, Pifferi A, Taroni P et al (1999) Fluorescence lifetime imaging: an application to the detection of skin tumors. IEEE J Sel Top Quantum Electron 5:923–929.  https://doi.org/10.1109/2944.796312CrossRefGoogle Scholar
  16. 16.
    Daldrup-Link HE, Brasch RC (2003) Macromolecular contrast agents for MR mammography: current status. Eur Radiol 13:354–365.  https://doi.org/10.1007/s00330-002-1719-1CrossRefPubMedGoogle Scholar
  17. 17.
    Desmettre T, Devoisselle JM, Mordon S (2000) Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol 45:15–27. https://doi.org/10.1016/S0039-6257(00)00123-5CrossRefPubMedGoogle Scholar
  18. 18.
    Dlugosz A, Barakat AM, Björkström NK et al (2016) Diagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study. Endosc Int Open 4:E901–E911.  https://doi.org/10.1055/s-0042-111203CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    DSouza AV, Lin H, Henderson ER et al (2016) Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J Biomed Opt 21:80901.  https://doi.org/10.1117/1.JBO.21.8.080901
  20. 20.
    Ebert B, Sukowski U, Grosenick D et al (2001) Near-infrared fluorescent dyes for enhanced contrast in optical mammography: phantom experiments. J Biomed Opt 6:134–140.  https://doi.org/10.1117/1.1350561CrossRefPubMedGoogle Scholar
  21. 21.
    Enfield LC, Gibson AP, Everdell NL et al (2007) Three-dimensional time-resolved optical mammography of the uncompressed breast. Appl Opt 46:3628–3638. https://doi.org/10.1364/ao.46.003628CrossRefPubMedGoogle Scholar
  22. 22.
    Fang Q, Selb J, Carp SA et al (2011) Combined optical and X-ray tomosynthesis breast imaging. Radiology 258:89–97.  https://doi.org/10.1148/radiol.10082176CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Feng Y, Jeong E-K, Mohs AM et al (2008) Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice. Magn Reson Med 60:1347–1352.  https://doi.org/10.1002/mrm.21791CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Fischer T, Ebert B, Voigt J et al (2010) Detection of rheumatoid arthritis using non-specific contrast enhanced fluorescence imaging. Acad Radiol 17:375–381.  https://doi.org/10.1016/j.acra.2009.09.016CrossRefPubMedGoogle Scholar
  25. 25.
    Floery D, Helbich TH, Riedl CC et al (2005) Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM). Invest Radiol 40:328–335.  https://doi.org/10.1097/01.rli.0000164487.60548.28CrossRefPubMedGoogle Scholar
  26. 26.
    Fukuda H, Casas A, Batlle A (2005) Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy. Int J Biochem Cell Biol 37:272–276.  https://doi.org/10.1016/j.biocel.2004.04.018CrossRefPubMedGoogle Scholar
  27. 27.
    Fusco V, Ebert B, Weber-Eibel J et al (2012) Cancer prevention in ulcerative colitis: long-term outcome following fluorescence-guided colonoscopy. Inflamm Bowel Dis 18:489–495.  https://doi.org/10.1002/ibd.21703CrossRefPubMedGoogle Scholar
  28. 28.
    Galanopoulos M, Tsoukali E, Gkeros F et al (2018) Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand? World J Gastrointest Endosc 10:250–258.  https://doi.org/10.4253/wjge.v10.i10.250CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Giacchino M, Bansal A, Kim RE et al (2013) Clinical utility and interobserver agreement of autofluorescence imaging and magnification narrow-band imaging for the evaluation of Barrett’s esophagus: a prospective tandem study. Gastrointest Endosc 77:711–718.  https://doi.org/10.1016/j.gie.2013.01.029CrossRefPubMedGoogle Scholar
  30. 30.
    Goetz M, Kiesslich R (2008) Confocal endomicroscopy: in vivo diagnosis of neoplastic lesions of the gastrointestinal tract. Anticancer Res 28:353–360PubMedGoogle Scholar
  31. 31.
    Götz L, Heywang-Kobrunner S, Schütz O, Siebold H (1998) Optische Mammographie an präoperativen Patientinnen. Aktuelle Radiol 8:31–33PubMedGoogle Scholar
  32. 32.
    Greenbaum L, Katcoff DJ, Dou H et al (2003) A porphobilinogen deaminase (PBGD) Ran-binding protein interaction is implicated in nuclear trafficking of PBGD in differentiating glioma cells. Oncogene 22:5221–5228.  https://doi.org/10.1038/sj.onc.1206723CrossRefPubMedGoogle Scholar
  33. 33.
    Grosenick D, Wabnitz H, Rinneberg H et al (1999) Development of a time-domain optical mammograph and first in vivo applications. Appl Opt 38:2927.  https://doi.org/10.1364/AO.38.002927CrossRefPubMedGoogle Scholar
  34. 34.
    Grosenick D, Hagen A, Steinkellner O et al (2011) A multichannel time-domain scanning fluorescence mammograph: performance assessment and first in vivo results. Rev Sci Instrum 82:024302.  https://doi.org/10.1063/1.3543820CrossRefPubMedGoogle Scholar
  35. 35.
    Grosenick D, Rinneberg H, Cubeddu R, Taroni P (2016) Review of optical breast imaging and spectroscopy. J Biomed Opt 21:091311.  https://doi.org/10.1117/1.JBO.21.9.091311CrossRefPubMedGoogle Scholar
  36. 36.
    Hagen A, Grosenick D, Macdonald R et al (2009) Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions. Opt Express 17:17016.  https://doi.org/10.1364/OE.17.017016CrossRefPubMedGoogle Scholar
  37. 37.
    Hautmann H, Pichler JP, Stepp H et al (2007) In-vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Respir Res 8:33.  https://doi.org/10.1186/1465-9921-8-33CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Hsiung P-L, Hardy J, Friedland S et al (2008) Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med 14:454–458.  https://doi.org/10.1038/nm1692CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Hundorfean G, Pereira SP, Karstensen JG et al (2018) Modern endoscopic imaging in diagnosis and surveillance of inflammatory bowel disease patients. Gastroenterol Res Pract 2018:5738068.  https://doi.org/10.1155/2018/5738068CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Hurlstone D, Sanders D, McAlindon M et al (2006) High-magnification chromoscopic colonoscopy in ulcerative colitis: a valid tool for in vivo optical biopsy and assessment of disease extent. Endoscopy 38:1213–1217.  https://doi.org/10.1055/s-2006-944732CrossRefPubMedGoogle Scholar
  41. 41.
    Ignjatovic A, East JE, Subramanian V et al (2012) Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 107:885–890.  https://doi.org/10.1038/ajg.2012.67CrossRefPubMedGoogle Scholar
  42. 42.
    Intes X, Ripoll J, Chen Y et al (2003) In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. Med Phys 30:1039.  https://doi.org/10.1118/1.1573791CrossRefPubMedGoogle Scholar
  43. 43.
    Jocham D, Stepp H, Waidelich R (2008) Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 53:1138–1150.  https://doi.org/10.1016/j.eururo.2007.11.048CrossRefPubMedGoogle Scholar
  44. 44.
    Joshi BP, Wang TD (2018) Targeted optical imaging agents in cancer: focus on clinical applications. Contrast Media Mol Imaging 2018:2015237.  https://doi.org/10.1155/2018/2015237CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Joshi BP, Duan X, Kwon RS et al (2016) Multimodal endoscope can quantify wide-field fluorescence detection of Barrett’s neoplasia. Endoscopy 48:A1–A13.  https://doi.org/10.1055/s-0034-1392803CrossRefPubMedGoogle Scholar
  46. 46.
    Joshi BP, Dai Z, Gao Z et al (2017) Detection of sessile serrated adenomas in the proximal colon using wide-field fluorescence endoscopy. Gastroenterology 152:1002–1013.e9.  https://doi.org/10.1053/j.gastro.2016.12.009CrossRefPubMedGoogle Scholar
  47. 47.
    Kemmner W, Wan K, Rüttinger S et al (2008) Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 22:500–509.  https://doi.org/10.1096/fj.07-8888comCrossRefPubMedGoogle Scholar
  48. 48.
    Kiesslich R, Fritsch J, Holtmann M et al (2003) Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124:880–888.  https://doi.org/10.1053/gast.2003.50146CrossRefPubMedGoogle Scholar
  49. 49.
    Kitai T, Inomoto T, Miwa M, Shikayama T (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211–215. https://doi.org/10.2325/jbcs.12.211CrossRefPubMedGoogle Scholar
  50. 50.
    Laine L, Kaltenbach T, Barkun A et al (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 81:489–501.e26.  https://doi.org/10.1016/j.gie.2014.12.009CrossRefPubMedGoogle Scholar
  51. 51.
    Lamberts LE, Koch M, de Jong JS et al (2017) Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study. Clin Cancer Res 23:2730–2741.  https://doi.org/10.1158/1078-0432.CCR-16-0437CrossRefPubMedGoogle Scholar
  52. 52.
    Leifeld L, Rogler G, Stallmach A et al (2015) White-light or narrow-band imaging colonoscopy in surveillance of ulcerative colitis: a prospective multicenter study. Clin Gastroenterol Hepatol 13:1776–1781.e1.  https://doi.org/10.1016/j.cgh.2015.04.172CrossRefPubMedGoogle Scholar
  53. 53.
    Liebert A, Wabnitz H, Obrig H et al (2006) Non-invasive detection of fluorescence from exogenous chromophores in the adult human brain. Neuroimage 31:600–608.  https://doi.org/10.1016/j.neuroimage.2005.12.046CrossRefPubMedGoogle Scholar
  54. 54.
    Liu Y, Tamimi RM, Collins LC et al (2011) The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study. Breast Cancer Res Treat 129:175–184.  https://doi.org/10.1007/s10549-011-1432-3CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Maeda H, Wu J, Sawa T et al (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284. https://doi.org/10.1016/s0168-3659(99)00248-5CrossRefGoogle Scholar
  56. 56.
    Mahmood U (2004) Near infrared optical applications in molecular imaging. Earlier, more accurate assessment of disease presence, disease course, and efficacy of disease treatment. IEEE Eng Med Biol Mag 23:58–66. https://doi.org/10.1109/MEMB.2004.1337950CrossRefPubMedGoogle Scholar
  57. 57.
    Mayinger B, Neidhardt S, Reh H et al (2001) Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions. Gastrointest Endosc 54:572–578. https://doi.org/10.1067/mge.2001.118642CrossRefPubMedGoogle Scholar
  58. 58.
    Miampamba M, Liu J, Harootunian A et al (2017) Sensitive in vivo visualization of breast cancer using ratiometric protease-activatable fluorescent imaging agent, AVB-620. Theranostics 7:3369–3386.  https://doi.org/10.7150/thno.20678CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Moesta KT, Ebert B, Handke T et al (2001) Protoporphyrin IX occurs naturally in colorectal cancers and their metastases. Cancer Res 61:991–999PubMedGoogle Scholar
  60. 60.
    Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY et al (2015) Chromoendoscopy for surveillance in inflammatory bowel disease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: results from a large retrospective study. Am J Gastroenterol 110:1014–1021.  https://doi.org/10.1038/ajg.2015.63CrossRefPubMedGoogle Scholar
  61. 61.
    Nagaya T, Nakamura YA, Choyke PL, Kobayashi H (2017) Fluorescence-guided surgery. Front Oncol 7:314.  https://doi.org/10.3389/fonc.2017.00314CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Nagengast WB, Hartmans E, Garcia-Allende PB et al (2019) Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A. Gut 68:7–10.  https://doi.org/10.1136/gutjnl-2017-314953CrossRefPubMedGoogle Scholar
  63. 63.
    Ntziachristos V, Yodh AG, Schnall MD, Chance B (2000) Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci USA 97:2767–2772.  https://doi.org/10.1073/pnas.040570597CrossRefPubMedGoogle Scholar
  64. 64.
    Ntziachristos V, Yodh AG, Schnall MD, Chance B (2002) MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 4:347–354.  https://doi.org/10.1038/sj.neo.7900244CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Ortner M-A, Ebert B, Hein E et al (2003) Time gated fluorescence spectroscopy in Barrett’s oesophagus. Gut 52:28–33.  https://doi.org/10.1136/gut.52.1.28CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Ortner M-A, Fusco V, Ebert B et al (2010) Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis. Gastrointest Endosc 71:312–318.  https://doi.org/10.1016/j.gie.2009.09.029CrossRefPubMedGoogle Scholar
  67. 67.
    Panjehpour M, Overholt BF, Vo-Dinh T et al (1996) Endoscopic fluorescence detection of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 111:93–101. https://doi.org/10.1053/gast.1996.v111.pm8698231CrossRefPubMedGoogle Scholar
  68. 68.
    Perlitz C, Licha K, Scholle F-D et al (2005) Comparison of two tricarbocyanine-based dyes for fluorescence optical imaging. J Fluoresc 15:443–454.  https://doi.org/10.1007/s10895-005-2636-xCrossRefPubMedGoogle Scholar
  69. 69.
    Pleijhuis RG, Graafland M, de Vries J et al (2009) Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol 16:2717–2730.  https://doi.org/10.1245/s10434-009-0609-zCrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Poellinger A, Burock S, Grosenick D et al (2011) Breast cancer: early-and late-fluorescence near-infrared imaging with indocyanine green—a preliminary study. Radiology 258:409–416.  https://doi.org/10.1148/radiol.10100258CrossRefPubMedGoogle Scholar
  71. 71.
    Poellinger A, Persigehl T, Mahler M et al (2011) Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial. Invest Radiol 46:697–704.  https://doi.org/10.1097/RLI.0b013e318229ff25CrossRefPubMedGoogle Scholar
  72. 72.
    Pogue BW, Zhu TC, Ntziachristos V et al (2018) Fluorescence-guided surgery and intervention—an AAPM emerging technology blue paper. Med Phys 45:2681–2688.  https://doi.org/10.1002/mp.12909CrossRefPubMedGoogle Scholar
  73. 73.
    Polom K, Murawa D, Rho Y-S et al (2011) Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer 117:4812–4822.  https://doi.org/10.1002/cncr.26087CrossRefPubMedGoogle Scholar
  74. 74.
    Quarto G, Spinelli L, Pifferi A et al (2014) Estimate of tissue composition in malignant and benign breast lesions by time-domain optical mammography. Biomed Opt Express 5:3684–3698.  https://doi.org/10.1364/BOE.5.003684CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Richards-Kortum R, Sevick-Muraca E (1996) Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem 47:555–606.  https://doi.org/10.1146/annurev.physchem.47.1.555CrossRefPubMedGoogle Scholar
  76. 76.
    Riefke B, Licha K, Semmler W et al (1996) In vivo characterization of cyanine dyes as contrast agents for near-infrared imaging. Proc SPIE 2927:199–208.  https://doi.org/10.1117/12.260652CrossRefGoogle Scholar
  77. 77.
    Rinneberg H, Grosenick D, Moesta KT et al (2005) Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo. Technol Cancer Res Treat 4:483–496.  https://doi.org/10.1177/153303460500400503CrossRefPubMedGoogle Scholar
  78. 78.
    Rinneberg H, Grosenick D, Moesta KT et al (2008) Detection and characterization of breast tumours by time-domain scanning optical mammography. Opto-Electron Rev 16:147–162.  https://doi.org/10.2478/s11772-008-0004-5CrossRefGoogle Scholar
  79. 79.
    Rispo A, Castiglione F, Staibano S et al (2012) Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis. World J Gastrointest Endosc 4:414.  https://doi.org/10.4253/wjge.v4.i9.414CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Rubin DT, Rothe JA, Hetzel JT et al (2007) Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 65:998–1004.  https://doi.org/10.1016/j.gie.2006.09.025CrossRefPubMedGoogle Scholar
  81. 81.
    Schaafsma BE, van de Giessen M, Charehbili A et al (2015) Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer. Clin Cancer Res 21:577–584.  https://doi.org/10.1158/1078-0432.CCR-14-0736CrossRefPubMedGoogle Scholar
  82. 82.
    Schäfer VS, Hartung W, Hoffstetter P et al (2013) Quantitative assessment of synovitis in patients with rheumatoid arthritis using fluorescence optical imaging. Arthritis Res Ther 15:R124.  https://doi.org/10.1186/ar4304CrossRefPubMedPubMedCentralGoogle Scholar
  83. 83.
    Soetikno R, Subramanian V, Kaltenbach T et al (2013) The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 144:1349–1352.e6.  https://doi.org/10.1053/j.gastro.2013.04.008CrossRefPubMedGoogle Scholar
  84. 84.
    Srinivasan S, Carpenter CM, Ghadyani HR et al (2010) Image guided near-infrared spectroscopy of breast tissue in vivo using boundary element method. J Biomed Opt 15:061703.  https://doi.org/10.1117/1.3499419CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    Sturm MB, Joshi BP, Lu S et al (2013) Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci Transl Med 5:184ra61–184ra61.  https://doi.org/10.1126/scitranslmed.3004733
  86. 86.
    Szyc Ł, Bonifer S, Walter A et al (2015) Development of a handheld fluorescence imaging camera for intraoperative sentinel lymph node mapping. J Biomed Opt 20:051025.  https://doi.org/10.1117/1.JBO.20.5.051025CrossRefPubMedGoogle Scholar
  87. 87.
    Taroni P, Quarto G, Pifferi A et al (2015) Breast tissue composition and its dependence on demographic risk factors for breast cancer: non-invasive assessment by time domain diffuse optical spectroscopy. PLoS ONE 10:e0128941.  https://doi.org/10.1371/journal.pone.0128941CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Ter Weele EJ, Terwisscha van Scheltinga AGT, Linssen MD et al (2016) Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use. Eur J Pharm Biopharm 104:226–234.  https://doi.org/10.1016/j.ejpb.2016.05.008CrossRefPubMedGoogle Scholar
  89. 89.
    Themelis G, Yoo JS, Soh K-S et al (2009) Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt 14:064012.  https://doi.org/10.1117/1.3259362CrossRefPubMedGoogle Scholar
  90. 90.
    Tipirneni KE, Warram JM, Moore LS et al (2017) Oncologic procedures amenable to fluorescence-guided surgery. Ann Surg 266:36–47.  https://doi.org/10.1097/SLA.0000000000002127CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Tromberg BJ, L’Heureux D, Mankoff D et al (2011) OT2-05-02: ACRIN 6691 monitoring and predicting breast cancer neoadjuvant chemotherapy response using diffuse optical spectroscopic imaging (DOSI). Cancer Res 71:OT2-05–02.  https://doi.org/10.1158/0008-5472.sabcs11-ot2-05-02
  92. 92.
    Troyan SL, Kianzad V, Gibbs-Strauss SL et al (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16:2943–2952.  https://doi.org/10.1245/s10434-009-0594-2CrossRefPubMedPubMedCentralGoogle Scholar
  93. 93.
    Tummers QRJG, Verbeek FPR, Schaafsma BE et al (2014) Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and Methylene Blue. Eur J Surg Oncol 40:850–858.  https://doi.org/10.1016/j.ejso.2014.02.225CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Tummers QRJG, Hoogstins CES, Gaarenstroom KN et al (2016) Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17. Oncotarget 7:32144–32155.  https://doi.org/10.18632/oncotarget.8282CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
    Unkart JT, Chen SL, Wapnir IL et al (2017) Intraoperative tumor detection using a ratiometric activatable fluorescent peptide: a first-in-human phase 1 study. Ann Surg Oncol 24:3167–3173.  https://doi.org/10.1245/s10434-017-5991-3CrossRefPubMedGoogle Scholar
  96. 96.
    van Brussel ASA, Adams A, Oliveira S et al (2016) Hypoxia-targeting fluorescent nanobodies for optical molecular imaging of pre-invasive breast cancer. Mol Imaging Biol 18:535–544.  https://doi.org/10.1007/s11307-015-0909-6CrossRefPubMedGoogle Scholar
  97. 97.
    van de Ven SMWY, Wiethoff A, Nielsen T et al (2010) A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients. Mol Imaging Biol 12:343–348.  https://doi.org/10.1007/s11307-009-0269-1CrossRefPubMedGoogle Scholar
  98. 98.
    van den Broek FJC, van Es JA, van Eeden S et al (2011) Pilot study of probe-based confocal laser endomicroscopy during colonoscopic surveillance of patients with longstanding ulcerative colitis. Endoscopy 43:116–122.  https://doi.org/10.1055/s-0030-1255954CrossRefPubMedGoogle Scholar
  99. 99.
    Vaupel P, Schlenger K, Knoop C, Höckel M (1991) Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51:3316–3322PubMedGoogle Scholar
  100. 100.
    Vavadi H, Mostafa A, Zhou F et al (2018) Compact ultrasound-guided diffuse optical tomography system for breast cancer imaging. J Biomed Opt 24:1.  https://doi.org/10.1117/1.JBO.24.2.021203CrossRefPubMedGoogle Scholar
  101. 101.
    Vieth M, Ell C, Gossner L et al (2004) Histological analysis of endoscopic resection specimens from 326 patients with Barrett’s esophagus and early neoplasia. Endoscopy 36:776–781.  https://doi.org/10.1055/s-2004-825802CrossRefPubMedGoogle Scholar
  102. 102.
    Wagnieres G, Hadjur C, Grosjean P et al (1998) Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin. Photochem Photobiol 68:382–387CrossRefPubMedGoogle Scholar
  103. 103.
    Wanders LK, Kuiper T, Kiesslich R et al (2016) Limited applicability of chromoendoscopy-guided confocal laser endomicroscopy as daily-practice surveillance strategy in Crohn’s disease. Gastrointest Endosc 83:966–971.  https://doi.org/10.1016/j.gie.2015.09.001CrossRefPubMedGoogle Scholar
  104. 104.
    Wang KK, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797.  https://doi.org/10.1111/j.1572-0241.2008.01835.xCrossRefGoogle Scholar
  105. 105.
    Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316–333. https://doi.org/10.1148/radiology.219.2.r01ma19316CrossRefGoogle Scholar
  106. 106.
    Weissleder R, Tung CH, Mahmood U, Bogdanov A (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375–378.  https://doi.org/10.1038/7933CrossRefPubMedGoogle Scholar
  107. 107.
    Whitley MJ, Cardona DM, Lazarides AL et al (2016) A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. Sci Transl Med 8:320ra4.  https://doi.org/10.1126/scitranslmed.aad0293
  108. 108.
    Yan Y, Sun X, Shen B (2017) Contrast agents in dynamic contrast-enhanced magnetic resonance imaging. Oncotarget 8:43491–43505.  https://doi.org/10.18632/oncotarget.16482CrossRefPubMedPubMedCentralGoogle Scholar
  109. 109.
    Zeng H-C, Hu J-L, Bai J-W, Zhang G-J (2018) Detection of sentinel lymph nodes with near-infrared imaging in malignancies. Mol Imaging Biol.  https://doi.org/10.1007/s11307-018-1237-4CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Physikalisch-Technische Bundesanstalt (PTB)BerlinGermany
  2. 2.Klinik für Radiologie, St. Franziskus Hospital GmbHMünsterGermany

Personalised recommendations

Cite chapter

Buy options